Company News
Sunresin Completes Strategic Investment in FENGXINZE to Further Expand Industrial Chromatography Business
Sunresin recently completed a strategic investment in FENGXINZE, further expanding its business footprint in industrial chromatography and strengthening its presence in the life science separation and purification sector.
Sunresin Showcases Global Environmental Solutions at IFAT Munich 2026
IFAT Munich 2026 marked Sunresin’s largest overseas exhibition of the year. The company unveiled a newly designed custom-built booth featuring a modern, open, and international design concept, comprehensively showcasing its technologies and application solutions in environmental protection and resource recovery.
Sunresin Selected for Morgan Stanley’s “China Best Business Models 2.0” List, Recognized for Strong Competitive Advantages
Sunresin (300487.SZ), a global leader in adsorption and separation materials, has been selected for Morgan Stanley’s “China Best Business Models 2.0” list.
Sunresin Establishes Subsidiary in Sweden to Strengthen Global Life Sciences Strategy
Sunresin is pleased to announce the establishment of its new subsidiary and European Regional Headquarters for Life Sciences in Sweden.
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
Company
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091